BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19211603)

  • 21. Evaluating internal and ocular residual astigmatism in Chinese myopic children.
    Liu Y; Cheng Y; Zhang Y; Zhang L; Zhao M; Wang K
    Jpn J Ophthalmol; 2017 Nov; 61(6):494-504. PubMed ID: 28983803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%.
    Chia A; Chua WH; Wen L; Fong A; Goon YY; Tan D
    Am J Ophthalmol; 2014 Feb; 157(2):451-457.e1. PubMed ID: 24315293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of childhood myopia with atropine eyedrops and bifocal spectacles.
    Chiang MF; Kouzis A; Pointer RW; Repka MX
    Binocul Vis Strabismus Q; 2001; 16(3):209-15. PubMed ID: 11511288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of unilateral topical atropine on binocular pupil responses and eye growth in mice.
    Barathi VA; Beuerman RW; Schaeffel F
    Vision Res; 2009 Feb; 49(3):383-7. PubMed ID: 19059278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study.
    Fan DS; Lam DS; Chan CK; Fan AH; Cheung EY; Rao SK
    Jpn J Ophthalmol; 2007; 51(1):27-33. PubMed ID: 17295137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifocal electroretinogram in children on atropine treatment for myopia.
    Luu CD; Lau AM; Koh AH; Tan D
    Br J Ophthalmol; 2005 Feb; 89(2):151-3. PubMed ID: 15665343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effect of atropine 1% in children with low myopia.
    Yi S; Huang Y; Yu SZ; Chen XJ; Yi H; Zeng XL
    J AAPOS; 2015 Oct; 19(5):426-9. PubMed ID: 26228967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of aberrometer and autorefractor measures of refractive error in children.
    Martinez AA; Pandian A; Sankaridurg P; Rose K; Huynh SC; Mitchell P
    Optom Vis Sci; 2006 Nov; 83(11):811-7. PubMed ID: 17106401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astigmatism among myopics and its changes from childhood to adult age: a 23-year follow-up study.
    Pärssinen O; Kauppinen M; Viljanen A
    Acta Ophthalmol; 2015 May; 93(3):276-83. PubMed ID: 25384542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term results of using low-concentration atropine eye drops for controlling myopia progression in schoolchildren.
    Wu PC; Yang YH; Fang PC
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):461-6. PubMed ID: 21815829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Low-Concentration Atropine Eye Drops in Controlling the Progression of Myopia in Children: A One- and Two-Year Follow-Up Study.
    Zhang H; Yang P; Li Y; Zhang W; Li S
    Ophthalmic Epidemiol; 2024 Jun; 31(3):240-248. PubMed ID: 37528608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
    JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia.
    Siatkowski RM; Cotter SA; Crockett RS; Miller JM; Novack GD; Zadnik K;
    J AAPOS; 2008 Aug; 12(4):332-9. PubMed ID: 18359651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 0.02% and 0.01% atropine on ocular biometrics: A two-year clinical trial.
    Wang M; Cui C; Yu SA; Liang LL; Ma JX; Fu AC
    Front Pediatr; 2023; 11():1095495. PubMed ID: 36733432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atropine and bifocals can slow the progression of myopia in children.
    Syniuta LA; Isenberg SJ
    Binocul Vis Strabismus Q; 2001; 16(3):203-8. PubMed ID: 11511287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of myopia onset with 0.025% atropine in premyopic children.
    Fang PC; Chung MY; Yu HJ; Wu PC
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):341-5. PubMed ID: 20698798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
    Repka MX; Weise KK; Chandler DL; Wu R; Melia BM; Manny RE; Kehler LAF; Jordan CO; Raghuram A; Summers AI; Lee KA; Petersen DB; Erzurum SA; Pang Y; Lenhart PD; Ticho BH; Beck RW; Kraker RT; Holmes JM; Cotter SA;
    JAMA Ophthalmol; 2023 Aug; 141(8):756-765. PubMed ID: 37440213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
    Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A
    Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 0.05% racanisodamine on pupil size and accommodation.
    Chen Z; Li T; Yao P; Xu Y; Zhou X
    Optom Vis Sci; 2010 Dec; 87(12):966-70. PubMed ID: 20935583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Astigmatism and its components in 6-year-old children.
    Huynh SC; Kifley A; Rose KA; Morgan I; Heller GZ; Mitchell P
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):55-64. PubMed ID: 16384944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.